Steven Cohen’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
BBA
Steven Cohen's NGNE Position: Q3 2026 in Review
Steven Cohen increased its Neurogene (NGNE) stake by 68% in Q3 2026, buying an estimated $3.46M and bringing the position to 238,967 shares worth $6.65M. The position accounts for 0.01% of the portfolio, ranked #1617.
Steven Cohen first reported a position in NGNE in Q4 2017 and has held it in 22 quarters since. The position peaked at $16.9M in Q4 2020. 131 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.
- Steven Cohen held 238,967 shares of Neurogene worth $6.65M as of Q3 2026.
- Steven Cohen bought 97,047 Neurogene shares in Q3 2026, an estimated $3.46M.
- Neurogene made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1617 holding.
- Steven Cohen first reported a position in Neurogene in Q4 2017 and has held it in 22 quarters since.
- Steven Cohen's Neurogene position peaked at $16.9M in Q4 2020.
- 131 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.